{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:36:19Z","timestamp":1747204579158,"version":"3.40.5"},"posted":{"date-parts":[[2023,4,12]]},"group-title":"In Review","reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,3,31]]},"abstract":"<title>Abstract<\/title>\n        <p>X-linked hypophosphatemia (XLH) is a rare disease of elevated fibroblast growth factor 23 (FGF23) production that leads to hypophosphatemia and poor mineralization of bone and teeth. The clinical manifestations of XLH include a high prevalence of dental abscesses, likely driven by poorly formed structures of the dentoalveolar complex, including the alveolar bone, cementum, dentin, and periodontal ligament. Our previous studies have demonstrated that sclerostin antibody (Scl-Ab) treatment improves phosphate homeostasis, and increases bone mass, strength and mineralization in the <italic>Hyp<\/italic> mouse model of XLH. In the current study, we investigated whether Scl-Ab impacts the dentoalveolar structures of <italic>Hyp<\/italic> mice. Male and female wild-type and <italic>Hyp<\/italic> littermates were injected with 25 mg\/kg of vehicle or Scl-Ab twice weekly beginning at 12 weeks of age and euthanized at 20 weeks of age. Scl-Ab increased alveolar bone mass in both male and female mice and alveolar tissue mineral density in the male mice. The positive effects of Scl-Ab were consistent with an increase in the fraction of active (non-phosphorylated) \u03b2-catenin stained alveolar osteocytes. Scl-Ab had no effect on mineralized tissues of the tooth - dentin, enamel, acellular and cellular cementum. There was a non-significant trend toward increased periodontal ligament (PDL) attachment fraction within the Hyp mice. Additional PDL fibral structural parameters were not affected by Scl-Ab. The current study demonstrates that Scl-Ab can improve alveolar bone in the <italic>Hyp<\/italic> mouse model of XLH.<\/p>","DOI":"10.21203\/rs.3.rs-2762671\/v1","type":"posted-content","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T20:37:01Z","timestamp":1681331821000},"source":"Crossref","is-referenced-by-count":0,"title":["Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-Linked Hypophosphatemia (XLH)"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3760-234X","authenticated-orcid":false,"given":"Ryan","family":"Ross","sequence":"first","affiliation":[{"name":"Rush University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Rush University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia","family":"Alkhatib","sequence":"additional","affiliation":[{"name":"Rush University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Dulion","sequence":"additional","affiliation":[{"name":"Rush University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Guirado","sequence":"additional","affiliation":[{"name":"UIC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreya","family":"Patel","sequence":"additional","affiliation":[{"name":"Rush University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghua","family":"Chen","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago College of Dentistry"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"George","sequence":"additional","affiliation":[{"name":"Department of Oral Biology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"L. A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter TO","year":"2011","unstructured":"Carpenter, T. O., Imel, E. A., Holm, I. A., Jan de Beur, S. M. & Insogna, K. L. A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res 26, 1381\u20131388, doi:10.1002\/jbmr.340 (2011).","journal-title":"J Bone Miner Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13005-019-0192-x","article-title":"Oral symptoms and oral health-related quality of life of individuals with x-linked hypophosphatemia","volume":"15","author":"Hanisch M","year":"2019","unstructured":"Hanisch, M., Bohner, L., Sabandal, M. M. I., Kleinheinz, J. & Jung, S. Oral symptoms and oral health-related quality of life of individuals with x-linked hypophosphatemia. Head & face medicine 15, 8\u20138, doi:10.1186\/s13005-019-0192-x (2019).","journal-title":"Head & face medicine"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1210\/js.2018-00365","article-title":"The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey","volume":"3","author":"Skrinar A","year":"2019","unstructured":"Skrinar, A. et al. The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey. J Endocr Soc 3, 1321\u20131334, doi:10.1210\/js.2018-00365 (2019).","journal-title":"J Endocr Soc"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/0022034516677528","article-title":"Phosphate and Vitamin D Prevent Periodontitis in X-Linked Hypophosphatemia","volume":"96","author":"Biosse Duplan M","year":"2017","unstructured":"Biosse Duplan, M. et al. Phosphate and Vitamin D Prevent Periodontitis in X-Linked Hypophosphatemia. J Dent Res 96, 388\u2013395, doi:10.1177\/0022034516677528 (2017).","journal-title":"J Dent Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2013-1009","article-title":"The rachitic tooth","volume":"35","author":"Foster BL","year":"2014","unstructured":"Foster, B. L., Nociti, F. H., Jr. & Somerman, M. J. The rachitic tooth. Endocr Rev 35, 1\u201334, doi:10.1210\/er.2013-1009 (2014).","journal-title":"Endocr Rev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/0022034520901719","article-title":"Dentoalveolar Defects in the Hyp Mouse Model of X-linked Hypophosphatemia","volume":"99","author":"Zhang H","year":"2020","unstructured":"Zhang, H. et al. Dentoalveolar Defects in the Hyp Mouse Model of X-linked Hypophosphatemia. J Dent Res 99, 419\u2013428, doi:10.1177\/0022034520901719 (2020).","journal-title":"J Dent Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1902\/jop.2009.090129","article-title":"Aberrant cementum phenotype associated with the hypophosphatemic hyp mouse","volume":"80","author":"Fong H","year":"2009","unstructured":"Fong, H. et al. Aberrant cementum phenotype associated with the hypophosphatemic hyp mouse. J Periodontol 80, 1348\u20131354, doi:10.1902\/jop.2009.090129 (2009).","journal-title":"J Periodontol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li X","year":"2008","unstructured":"Li, X. et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. Journal of Bone and Mineral Research 23, 860\u2013869 (2008).","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ijos.2014.12","article-title":"Dental and periodontal phenotype in sclerostin knockout mice","volume":"6","author":"Kuchler U","year":"2014","unstructured":"Kuchler, U. et al. Dental and periodontal phenotype in sclerostin knockout mice. Int J Oral Sci 6, 70\u201376, doi:10.1038\/ijos.2014.12 (2014).","journal-title":"Int J Oral Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"Bezooijen RL","year":"2004","unstructured":"van Bezooijen, R. L. et al. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J.Exp.Med. 199, 805\u2013814 (2004).","journal-title":"J.Exp.Med."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.aanat.2012.02.014","article-title":"Immunohistochemical evidence for sclerostin during cementogenesis in mice","volume":"194","author":"Lehnen SD","year":"2012","unstructured":"Lehnen, S. D., G\u00f6tz, W., Baxmann, M. & J\u00e4ger, A. Immunohistochemical evidence for sclerostin during cementogenesis in mice. Ann Anat 194, 415\u2013421, doi:10.1016\/j.aanat.2012.02.014 (2012).","journal-title":"Ann Anat"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1600-0765.2009.01227.x","article-title":"Localization of SOST\/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro","volume":"45","author":"Jager A","year":"2010","unstructured":"Jager, A., Gotz, W., Lossdorfer, S. & Rath-Deschner, B. Localization of SOST\/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro. J Periodontal Res 45, 246\u2013254, doi:10.1111\/j.1600-0765.2009.01227.x (2010).","journal-title":"J Periodontal Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/jcpe.13624","article-title":"Sclerostin in periodontal ligament: Homeostatic regulator in biophysical force-induced tooth movement","volume":"49","author":"Nam YS","year":"2022","unstructured":"Nam, Y. S. et al. Sclerostin in periodontal ligament: Homeostatic regulator in biophysical force-induced tooth movement. J Clin Periodontol 49, 932\u2013944, doi:10.1111\/jcpe.13624 (2022).","journal-title":"J Clin Periodontol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"116201","DOI":"10.1016\/j.bone.2021.116201","article-title":"Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice","volume":"154","author":"Carpenter KA","year":"2021","unstructured":"Carpenter, K. A. et al. Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice. Bone 154, 116201, doi:10.1016\/j.bone.2021.116201 (2021).","journal-title":"Bone"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/jbmr.3923","article-title":"Sclerostin Antibody Treatment Increases Bone Mass and Normalizes Circulating Phosphate Levels in Growing Hyp Mice","volume":"35","author":"Carpenter KA","year":"2020","unstructured":"Carpenter, K. A. & Ross, R. D. Sclerostin Antibody Treatment Increases Bone Mass and Normalizes Circulating Phosphate Levels in Growing Hyp Mice. J Bone Miner Res 35, 596\u2013607, doi:10.1002\/jbmr.3923 (2020).","journal-title":"J Bone Miner Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.yexcr.2014.01.018","article-title":"Multifunctional ECM proteins in bone and teeth","volume":"325","author":"Ravindran S","year":"2014","unstructured":"Ravindran, S. & George, A. Multifunctional ECM proteins in bone and teeth. Exp.Cell Res. 325, 148\u2013154 (2014).","journal-title":"Exp.Cell Res."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel EA","year":"2019","unstructured":"Imel, E. A. et al. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet 393, 2416\u20132427, doi:10.1016\/S0140-6736(19)30654-3 (2019).","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e10672","DOI":"10.1002\/jbm4.10672","article-title":"Burosumab and Dental Abscesses in Children With X-Linked Hypophosphatemia","volume":"6","author":"Gadion M","year":"2022","unstructured":"Gadion, M. et al. Burosumab and Dental Abscesses in Children With X-Linked Hypophosphatemia. JBMR Plus 6, e10672, doi:10.1002\/jbm4.10672 (2022).","journal-title":"JBMR Plus"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e3241-e3253","DOI":"10.1210\/clinem\/dgac296","article-title":"Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia","volume":"107","author":"Ward LM","year":"2022","unstructured":"Ward, L. M. et al. Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia. J Clin Endocrinol Metab 107, e3241-e3253, doi:10.1210\/clinem\/dgac296 (2022).","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1073\/pnas.73.12.4667","article-title":"Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets","volume":"73","author":"Eicher EM","year":"1976","unstructured":"Eicher, E. M., Southard, J. L., Scriver, C. R. & Glorieux, F. H. Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci U S A 73, 4667\u20134671, doi:10.1073\/pnas.73.12.4667 (1976).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.bone.2017.07.026","article-title":"Tissue-specific mineralization defects in the periodontium of the Hyp mouse model of X-linked hypophosphatemia","volume":"103","author":"Coyac BR","year":"2017","unstructured":"Coyac, B. R. et al. Tissue-specific mineralization defects in the periodontium of the Hyp mouse model of X-linked hypophosphatemia. Bone 103, 334\u2013346, doi:https:\/\/doi.org\/10.1016\/j.bone.2017.07.026 (2017).","journal-title":"Bone"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1177\/00220345211011041","article-title":"Effects of Active Vitamin D or FGF23 Antibody on Hyp Mice Dentoalveolar Tissues","volume":"100","author":"Lira dos Santos EJ","year":"2021","unstructured":"Lira dos Santos, E. J. et al. Effects of Active Vitamin D or FGF23 Antibody on Hyp Mice Dentoalveolar Tissues. Journal of Dental Research 100, 1482\u20131491, doi:10.1177\/00220345211011041 (2021).","journal-title":"Journal of Dental Research"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"972","DOI":"10.5603\/FM.a2020.0134","article-title":"Remodelling compartment in root cementum","volume":"80","author":"Brochado Martins JF","year":"2021","unstructured":"Brochado Martins, J. F. et al. Remodelling compartment in root cementum. Folia Morphol (Warsz) 80, 972\u2013979, doi:10.5603\/FM.a2020.0134 (2021).","journal-title":"Folia Morphol (Warsz)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01263","article-title":"Stress Distribution and Collagen Remodeling of Periodontal Ligament During Orthodontic Tooth Movement","volume":"10","author":"Li Z","year":"2019","unstructured":"Li, Z. et al. Stress Distribution and Collagen Remodeling of Periodontal Ligament During Orthodontic Tooth Movement. Frontiers in Pharmacology 10, doi:10.3389\/fphar.2019.01263 (2019).","journal-title":"Frontiers in Pharmacology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.matbio.2015.12.009","article-title":"Sclerostin antibody (Scl-Ab) improves osteomalacia phenotype in dentin matrix protein 1(Dmp1) knockout mice with little impact on serum levels of phosphorus and FGF23","volume":"52\u201354","author":"Ren Y","year":"2016","unstructured":"Ren, Y. et al. Sclerostin antibody (Scl-Ab) improves osteomalacia phenotype in dentin matrix protein 1(Dmp1) knockout mice with little impact on serum levels of phosphorus and FGF23. Matrix Biol 52\u201354, 151\u2013161, doi:10.1016\/j.matbio.2015.12.009 (2016).","journal-title":"Matrix Biol"},{"year":"2013","author":"Ryan ZC","key":"ref26","unstructured":"Ryan, Z. C. et al. Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium. Proc.Natl.Acad.Sci.U.S.A 110, 6199\u20136204 (2013)."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bone.2016.11.019","article-title":"Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia","volume":"95","author":"Boukpessi T","year":"2017","unstructured":"Boukpessi, T. et al. Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia. Bone 95, 151\u2013161, doi:10.1016\/j.bone.2016.11.019 (2017).","journal-title":"Bone"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/jbmr.4101","article-title":"Genetic Ablation of Osteopontin in Osteomalacic Hyp Mice Partially Rescues the Deficient Mineralization Without Correcting Hypophosphatemia","volume":"35","author":"Hoac B","year":"2020","unstructured":"Hoac, B. et al. Genetic Ablation of Osteopontin in Osteomalacic Hyp Mice Partially Rescues the Deficient Mineralization Without Correcting Hypophosphatemia. Journal of Bone and Mineral Research 35, 2032\u20132048, doi:https:\/\/doi.org\/10.1002\/jbmr.4101 (2020).","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e871-878","DOI":"10.1210\/clinem\/dgz203","article-title":"Prevalence and Mortality of Individuals With X-Linked Hypophosphatemia: A United Kingdom Real-World Data Analysis","volume":"105","author":"Hawley S","year":"2020","unstructured":"Hawley, S. et al. Prevalence and Mortality of Individuals With X-Linked Hypophosphatemia: A United Kingdom Real-World Data Analysis. J Clin Endocrinol Metab 105, e871-878, doi:10.1210\/clinem\/dgz203 (2020).","journal-title":"J Clin Endocrinol Metab"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.641543","article-title":"Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium","volume":"12","author":"Laurent MR","year":"2021","unstructured":"Laurent, M. R. et al. Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium. Frontiers in endocrinology 12, doi:10.3389\/fendo.2021.641543 (2021).","journal-title":"Frontiers in endocrinology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1530\/EJE-15-0515","article-title":"Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications","volume":"174","author":"Rafaelsen S","year":"2016","unstructured":"Rafaelsen, S., Johansson, S., R\u00e6der, H. & Bjerknes, R. Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications. European Journal of Endocrinology 174, 125\u2013136, doi:10.1530\/EJE-15-0515 (2016).","journal-title":"European Journal of Endocrinology"},{"key":"ref32","article-title":"Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double-blind, placebo-controlled study","author":"Padhi D","year":"2013","unstructured":"Padhi, D. et al. Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double-blind, placebo-controlled study. J Clin Pharmacol. (2013).","journal-title":"J Clin Pharmacol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"705505","DOI":"10.3389\/fgene.2021.705505","article-title":"Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta Mouse","volume":"12","author":"Cardinal M","year":"2021","unstructured":"Cardinal, M. et al. Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta Mouse. Front Genet 12, 705505, doi:10.3389\/fgene.2021.705505 (2021).","journal-title":"Front Genet"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1902\/jop.2011.100736","article-title":"Periodontal status of patients with hypophosphatemic rickets: a case series","volume":"82","author":"Ye L","year":"2011","unstructured":"Ye, L., Liu, R., White, N., Alon, U. S. & Cobb, C. M. Periodontal status of patients with hypophosphatemic rickets: a case series. J Periodontol 82, 1530\u20131535, doi:10.1902\/jop.2011.100736 (2011).","journal-title":"J Periodontol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jbmr.3038","article-title":"Sclerostin antibody administration converts bone lining cells into active osteoblasts","volume":"32","author":"Kim SW","year":"2017","unstructured":"Kim, S. W. et al. Sclerostin antibody administration converts bone lining cells into active osteoblasts. Journal of Bone and Mineral Research 32, 892\u2013901 (2017).","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.yrtph.2016.08.010","article-title":"Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study","volume":"81","author":"Chouinard L","year":"2016","unstructured":"Chouinard, L. et al. Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study. Regul Toxicol Pharmacol 81, 212\u2013222, doi:10.1016\/j.yrtph.2016.08.010 (2016).","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/0022034515610768","article-title":"DSPP Is Essential for Normal Development of the Dental-Craniofacial Complex","volume":"95","author":"Chen Y","year":"2016","unstructured":"Chen, Y., Zhang, Y., Ramachandran, A. & George, A. DSPP Is Essential for Normal Development of the Dental-Craniofacial Complex. J Dent Res 95, 302\u2013310, doi:10.1177\/0022034515610768 (2016).","journal-title":"J Dent Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e10474","DOI":"10.1002\/jbm4.10474","article-title":"Guidelines for Micro\u2013Computed Tomography Analysis of Rodent Dentoalveolar Tissues","volume":"5","author":"Chavez MB","year":"2021","unstructured":"Chavez, M. B. et al. Guidelines for Micro\u2013Computed Tomography Analysis of Rodent Dentoalveolar Tissues. JBMR Plus 5, e10474, doi:https:\/\/doi.org\/10.1002\/jbm4.10474 (2021).","journal-title":"JBMR Plus"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"16007","DOI":"10.1117\/1.Jbo.19.1.016007","article-title":"Computational segmentation of collagen fibers from second-harmonic generation images of breast cancer","volume":"19","author":"Bredfeldt JS","year":"2014","unstructured":"Bredfeldt, J. S. et al. Computational segmentation of collagen fibers from second-harmonic generation images of breast cancer. J Biomed Opt 19, 16007, doi:10.1117\/1.Jbo.19.1.016007 (2014).","journal-title":"J Biomed Opt"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/03008209909000703","article-title":"Recombinant expression and characterization of dentin matrix protein 1","volume":"40","author":"Srinivasan R","year":"1999","unstructured":"Srinivasan, R., Chen, B., Gorski, J. P. & George, A. Recombinant expression and characterization of dentin matrix protein 1. Connective Tissue Research 40, 251\u2013258 (1999).","journal-title":"Connective Tissue Research"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2762671\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2762671\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T21:20:59Z","timestamp":1697577659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2762671\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":40,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2762671\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41368-023-00252-1","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,4,12]]},"subtype":"preprint"}}